Sarah Glickman's Insider Trades & SAST Disclosures
Sarah Glickman's most recent trade in 2seventy bio Inc was a trade of 24,100 Stock Options (Right to buy) done . Disclosure was reported to the exchange on May 13, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Sarah Glickman.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 2seventy bio Inc | Sarah Glickman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 24,100 | 0 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | 13 May 2025 | 15,602 | 0 | - | - | Common Stock | ||
| 2seventy bio Inc | Sarah Glickman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 13 May 2025 | 12,050 | 15,602 | - | - | Common Stock | |
| Aptargroup Inc. | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 May 2025 | 1,069 | 3,076 (0%) | 0% | 0 | Common Stock | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 38,724 | 332,719 (0%) | 0% | 0 | Ordinary Shares | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 32,456 | 365,175 (0%) | 0% | 0 | Ordinary Shares | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.30 per share. | 25 Feb 2025 | 17,883 | 293,995 (0%) | 0% | 40.3 | 720,685 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.36 per share. | 25 Nov 2024 | 1,520 | 311,878 (0%) | 0% | 40.4 | 61,347 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 40.60 per share. | 23 Oct 2024 | 5,442 | 313,398 (0%) | 0% | 40.6 | 220,945 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 49.17 per share. | 26 Aug 2024 | 1,519 | 318,682 (0%) | 0% | 49.2 | 74,689 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 45.49 per share. | 23 Jul 2024 | 5,496 | 320,201 (0%) | 0% | 45.5 | 250,013 | Ordinary Shares |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 24,100 | 24,100 | - | - | Stock Options (Right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 12,050 | 27,652 | - | 0 | Common Stock | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 24 May 2024 | 1,535 | 325,697 (0%) | 0% | 39.0 | 59,850 | Ordinary Shares |
| Aptargroup Inc. | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2024 | 1,113 | 2,007 (0%) | 0% | 0 | Common Stock | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 35.40 per share. | 23 Apr 2024 | 5,504 | 327,232 (0%) | 0% | 35.4 | 194,836 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 39,717 | 332,736 (0%) | 0% | 0 | Ordinary Shares | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2024 | 52,966 | 302,672 (0%) | 0% | 0 | Ordinary Shares | |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 23 Feb 2024 | 9,653 | 293,019 (0%) | 0% | 32.7 | 315,557 | Ordinary Shares |
| Criteo S.A - ADR | Sarah Glickman | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 24.74 per share. | 23 Jan 2024 | 3,622 | 249,706 (0%) | 0% | 24.7 | 89,608 | Ordinary Shares |
| Aptargroup Inc. | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2023 | 894 | 894 (0%) | 0% | 0 | Common Stock | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 16,900 | 16,900 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 8,400 | 15,602 | - | 0 | Common Stock | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 14,400 | 14,400 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 4,200 | 7,202 | - | 0 | Common Stock | |
| Bluebird bio Inc | Sarah Glickman | Director | Other type of transaction at price $ 0.00 per share. | 11 Nov 2021 | 7,500 | 0 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 4,829 | 4,829 | - | - | Stock Option (right to buy) | |
| 2seventy bio Inc | Sarah Glickman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Nov 2021 | 3,002 | 3,002 | - | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges